Merck KGaA (OTCMKTS:MKGAF) Sets New 52-Week Low – What’s Next?

Merck KGaA (OTCMKTS:MKGAF) hit a new 52-week low on Tuesday . The stock traded as low as $116.68 and last traded at $125.0530, with a volume of 372 shares changing hands. The stock had previously closed at $120.51.

Merck KGaA Stock Performance

The stock has a market capitalization of $16.05 billion, a P/E ratio of 18.95 and a beta of 0.96. The company has a 50 day simple moving average of $144.23 and a 200-day simple moving average of $139.64. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.